Indeed, it was shown that ACE inhibition attenuated the superoxide-generating effects of angiotensin II, impaired the breakdown of bradykinin, and increased the production of EDNO in patients with coronary artery disease [50]. This evidence concerns the gene AGT and coronary artery disorder.